Search

Search Results

1. Cost-effectiveness thresholds or decision-making threshold: a novel perspective

   The use of multiple cost-effectiveness thresholds in pharmacoeconomic evaluation is a hotly debated topic in the international academic community....

   Lihua Sun, **aochen Peng, ... Zhe Huang in Cost Effectiveness and Resource Allocation

   Article Open access 03 October 2023

2. Framework for develo** cost-effectiveness analysis threshold: the case of Egypt

   Background

   Cost-effectiveness analyses rarely offer useful insights to policy decisions unless their results are compared against a benchmark...

   Ahmad N. Fasseeh, Nada Korra, ... Zoltán Kaló in Journal of the Egyptian Public Health Association

   Article Open access 03 June 2024
   

3. A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany

   Purpose

   Value-based pricing of new, innovative health technologies defined as pricing through economic evaluation requires the use of a basic...

   Afschin Gandjour in Applied Health Economics and Health Policy

   Article Open access 11 April 2023
   

4. Cost-effectiveness and threshold analysis of deep brain stimulation vs. treatment-as-usual for treatment-resistant depression

   Treatment-resistant depression (TRD) affects approximately 2.8 million people in the U.S. with estimated annual healthcare costs of $43.8 billion....

   Katherine E. Kabotyanski, Ricardo A. Najera, ... Sameer A. Sheth in Translational Psychiatry

   Article Open access 07 June 2024
   

5. Factors associated with the author-reported cost-effectiveness threshold in high-income countries: systematic review and multivariable modelling

   Objective

   The cost-effectiveness threshold (CET) is a key parameter to guide objective reimbursement decisions, yet very few countries have defined a...

   Nicolas Boespflug, Jérôme Wittwer, Antoine Bénard in The European Journal of Health Economics

   Article 11 July 2023
   

6. The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease

   The objective of this article was to assess the cost-effectiveness of screening strategies for cardiovascular diseases (CVD). A decision analytic...

   Zuzana Špacírová, Stephen Kaptoge, ... David Epstein in The European Journal of Health Economics

   Article 14 October 2022
   

7. Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method

   Objectives

   Monetizing health has sparked controversy and has implications for pricing strategies of emerging health technologies. Medical insurance...

   Qian Peng, Yue Yin, ... Wenxi Tang in Cost Effectiveness and Resource Allocation

   Article Open access 02 November 2023
   

8. Early Cost-Effectiveness and Price Threshold Analyses of Resmetirom: An Investigational Treatment for Management of Nonalcoholic Steatohepatitis

   Background

   Nonalcoholic steatohepatitis (NASH) is characterized by inflammation and hepatocellular damage caused by accumulation of fat in the liver....

   Mehdi Javanbakht, Jesse Fishman, ... Amir Ansaripour in PharmacoEconomics - Open

   Article Open access 14 September 2022
   

9. Cost Effectiveness of Zanubrutinib Versus Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

   Background

   While the efficacy and safety of zanubrutinib have been established in relapsed or refractory chronic lymphocytic leukemia, the evidence on...

   Dong-Won Kang, Li Wang, ... Chan Shen in PharmacoEconomics

   Article 06 January 2024
   

10. Cost-effectiveness analysis of nivolumab versus placebo for relapsed malignant mesothelioma

    Background

    Although nivolumab has shown clinical benefits for relapsed malignant mesothelioma, its cost-effectiveness requires further investigation.

    ...

    Wenwang Lang, Jiarong Wei, ... Yulong He in International Journal of Clinical Pharmacy

    Article 22 November 2023
    

11. The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice

    A cost-effectiveness analysis has become an important method to inform allocation decisions and reimbursement of new technologies in healthcare. A...

    Bram Wouterse, Pieter van Baal, ... Werner Brouwer in PharmacoEconomics

    Article Open access 18 April 2023

12. Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer

    Background

    Tamoxifen (TAM) is recommended as the first-line strategy for men with estrogen receptor (ER)-positive early breast cancer who are...

    Ya** Huang, Chengjie Ke, ... Hong Sun in Breast Cancer

    Article 15 June 2024
    

13. Cost Effectiveness of Deep Brain Stimulation for Parkinson’s Disease: A Systematic Review

    Background and Objective

    Deep brain stimulation (DBS) is an established treatment for Parkinson’s disease (PD) in patients with advanced motor...

    Akhil Sasidharan, Bhavani Shankara Bagepally, S Sajith Kumar in Applied Health Economics and Health Policy

    Article 28 November 2023
    

14. Cost-effectiveness analysis of metformin versus insulin in the treatment of gestational diabetes mellitus

    Objective

    Although there have been many studies on gestational diabetes mellitus (GDM) treatment, there is still a knowledge gap regarding the...

    Rui Wu, Zuo**g Li in Archives of Gynecology and Obstetrics

    Article 01 April 2024
    

15. Cost Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Patients with Elevated Low-Density Lipoprotein Cholesterol Despite Statin Use: A Threshold Analysis

    Background

    Inclisiran is a novel, cholesterol-lowering therapy, with a long duration of effect, administered every 6 months (subcutaneously by a...

    Nihar R. Desai, Caresse Campbell, ... Joaquim Cristino in American Journal of Cardiovascular Drugs

    Article Open access 21 May 2022
    

16. Risk-based lung cancer screening in heavy smokers: a benefit–harm and cost-effectiveness modeling study

    Background

    Annual screening through low-dose computed tomography (LDCT) is recommended for heavy smokers. However, it is questionable whether all...

    Yin Liu, Huifang Xu, ... Shaokai Zhang in BMC Medicine

    Article Open access 19 February 2024
    

17. Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China

    Background

    Glioblastoma (GBM) stands as the most aggressive and prevalent primary brain malignancy. Tumor Treating Fields (TTFields), an innovative...

    Yuliang **ang, Yingyao Chen, ... Shimeng Liu in Journal of Neuro-Oncology

    Article 02 April 2024
    

18. Common treatment strategies for calcium hydroxyapatite deposition disease: a cost-effectiveness analysis

    Objective

    To determine the cost-effectiveness of rotator cuff hydroxyapatite deposition disease (HADD) treatments.

    Method

    A 1-year time horizon...

    Erin F. Alaia, Naveen Subhas, ... Soterios Gyftopoulos in Skeletal Radiology

    Article 14 August 2023
    

19. Cost-effectiveness of weight-management pharmacotherapies in Canada: a societal perspective

    Objectives

    This study aimed to assess the cost-effectiveness of weight-management pharmacotherapies approved by Canada Health, i.e., orlistat,...

    Anamaria-Vera Olivieri, Sergey Muratov, ... David C. W. Lau in International Journal of Obesity

    Article Open access 31 January 2024
    

20. Cost-effectiveness analysis of biologics for the treatment of chronic rhinosinusitis with nasal polyps in Canada

    Background

    Dupilumab, omalizumab, and mepolizumab are the three biologics currently approved for use in CRSwNP in Canada. Despite evidence of...

    Michael Yong, Keshinisuthan Kirubalingam, ... Andrew Thamboo in Allergy, Asthma & Clinical Immunology

    Article Open access 14 October 2023